Imaging Features of Main Hepatic Resections: The Radiologist Challenging.
Carmen CutoloRoberta FuscoIgino SimonettiFederica De MuzioFrancesca GrassiPiero TrovatoPierpaolo PalumboFederico BrunoNicola MaggialettiAlessandra BorgheresiAlessandra BrunoGiuditta ChitiEleonora BicciMaria Chiara BruneseAndrea GiovagnoniVittorio MieleAntonio BarileFrancesco IzzoVincenza GranataPublished in: Journal of personalized medicine (2023)
Liver resection is still the most effective treatment of primary liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), and of metastatic disease, such as colorectal liver metastases. The type of liver resection (anatomic versus non anatomic resection) depends on different features, mainly on the type of malignancy (primary liver neoplasm versus metastatic lesion), size of tumor, its relation with blood and biliary vessels, and the volume of future liver remnant (FLT). Imaging plays a critical role in postoperative assessment, offering the possibility to recognize normal postoperative findings and potential complications. Ultrasonography (US) is the first-line diagnostic tool to use in post-surgical phase. However, computed tomography (CT), due to its comprehensive assessment, allows for a more accurate evaluation and more normal findings than the possible postoperative complications. Magnetic resonance imaging (MRI) with cholangiopancreatography (MRCP) and/or hepatospecific contrast agents remains the best tool for bile duct injuries diagnosis and for ischemic cholangitis evaluation. Consequently, radiologists should be familiar with the surgical approaches for a better comprehension of normal postoperative findings and of postoperative complications.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- computed tomography
- liver metastases
- high resolution
- patients undergoing
- magnetic resonance
- small cell lung cancer
- squamous cell carcinoma
- diffusion weighted imaging
- dual energy
- positron emission tomography
- acute myeloid leukemia
- image quality
- risk factors
- current status
- tyrosine kinase
- ischemia reperfusion injury
- fluorescence imaging
- blood brain barrier
- replacement therapy
- photodynamic therapy
- brain injury
- human health